McCormick's Solid Q3 Reaffirmation Fails to Resolve Deal Overhang

What happened

McCormick reported a solid third quarter and reaffirmed its fiscal 2026 outlook, but the press release provides no breakdown of organic growth, volume trends, or progress on the Unilever Foods combination. The master report already anticipated that near-term results would remain acquisition-led and that the core uncertainty is the pending Reverse Morris Trust transaction with $15.7 billion in cash financing needs and explicit antitrust divestiture risk. Without updates on the S-4 filing, shareholder vote timing, or permanent financing, this quarter's affirmation simply confirms the base business is tracking to the low-single-digit organic growth guidance. The market is likely to treat the news as a non-event while the stock continues to trade on deal mechanics rather than fundamentals. The WAIT rating remains appropriate until observable de-risking events occur.

Implication

The reaffirmed guidance supports the base case of adjusted EPS near $3.09 and organic growth of 1-3%, but that was already reflected in the $52 base-case implied value, leaving little upside from the quarter itself. The dominant risk remains the Unilever Foods transaction: without an S-4 filing, shareholder vote date, or progress on permanent financing, the stock will continue to carry an uncertainty discount. Investors should monitor whether competitive promotions stay contained and total company volumes turn positive, as that would strengthen the base business while the deal process plays out. However, even a solid quarter does not mitigate the binary risk of regulatory remedies or financing strain that could push the stock toward the $40 bear case. Patience is warranted; entry is more attractive near $45 or after clear de-risking signals.

Thesis delta

The Q3 reaffirmation does not materially shift the investment thesis. It confirms the base business is stable but does not address the deal overhang, which remains the primary driver of the stock's risk-reward over the next 6-12 months. The WAIT rating stands; no change in conviction until we see S-4 filing, vote timing, and permanent financing steps.